PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

And as already stated, ANP will not need a phase 3 trial if...

  1. Baremoney
    236 Posts.
    lightbulb Created with Sketch. 59
    clock Created with Sketch.
    28/10/20
    09:40
    Post #: 48442090
    And as already stated, ANP will not need a phase 3 trial if results of P2B are the same let alone better then P2A, then the drug approval should be granted.
    ANP Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 18  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $92.97K 1.150M

Buyers (Bids)

No. Vol. Price($)
4 77970 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 6739 1
View Market Depth
Last trade - 15.19pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.